We recently compiled a list of the 10 Best Micro Cap Stocks to Buy Now. In this article, we are going to take a look at where Cyclo Therapeutics, Inc. (NASDAQ:CYTH) stands against the other micro cap ...

As of February 10, 2023, the average one-year price target for Cyclo Therapeutics is $5.10. The forecasts range from a low of $5.05 to a high of $5.25. The average price target represents an increase ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Cyclo Therapeutics, Inc. (CYTH) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.29 per share a year ago. These ...

Clinical-stage biotechs Applied Molecular Transport (NASDAQ:AMTI) and Cyclo Therapeutics (NASDAQ:CYTH) announced a merger agreement on Thursday whereby Applied Molecular (AMTI) will merge with Cyclo ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Cyclo Therapeutics, Inc. (NASDAQ: CYTH) and Applied Molecular Transport Inc. is fair to ...

Ctd Holdings Inc (CYTH) stock has hit a 52-week low, dropping to $0.68, as the company faces a turbulent market environment. This new low reflects a significant downturn for the stock, which has seen ...